Dr. Puentes joined NeoGenomics as a Medical Science Liaison through Genoptix in 2018. Prior to this she received her PhD in molecular oncology under Dr. Garth Powis, director of the NCI-Designated Cancer Center at Sanford Burnham Prebys research institute in La Jolla, California. Dr. Puentes’ publications focus on novel molecular targets and drug development in solid tumor, with a focus on KRas-driven lung cancer. Dr. Puentes obtained her PharmD degree at the University College London, School of Pharmacy. She undertook her thesis research at the department of Experimental Therapeutics, MD Anderson Cancer Center, in Houston, TX. In 2013 she completed her clinical pharmacy residency at the University College London Hospital including clinical oncology at the MacMillan Cancer Centre. She is a member of Hematology Oncology Pharmacy Association (HOPA) and American Association for Cancer Research (AACR).
Róisín Puentes
Medical Science Liaison, Medical Affairs